Login / Signup

Metabolomics analysis of human plasma reveals decreased production of trimethylamine N-oxide retards the progression of chronic kidney disease.

Da-Yong HuMing-Yu WuGuang-Qi ChenBing-Qing DengHai-Bo YuJian HuangYing LuoMeng-Yuan LiDa-Ke ZhaoJun Yan Liu
Published in: British journal of pharmacology (2022)
Our data show that decreased TMAO production could be a new strategy to attenuate the progression of renal injury in CKD.
Keyphrases
  • chronic kidney disease
  • end stage renal disease
  • mass spectrometry
  • electronic health record
  • big data
  • peritoneal dialysis